Market Research Logo

Cough Suppressant Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Cough Suppressant Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

A cough is a most common symptom of various upper and lower respiratory tract infections. It affects a large proportion of the population leading them to seek medical attention. According to the data published by Journal of the Association of Physicians of India in 2016, cough was identified as the sixth most common reason for hospital outpatient department visits. Cough suppressants, also known as antitussives, are medications that help to suppress cough. Some of the examples of cough suppressants are Dextromethorphan, Codeine, Noscapine, Butamirate, Benzonatate, and Pholcodine. Dextromethorphan and Codeine are the most common and widely used cough suppressant in market.

Market Dynamics

Frequent launch of new cough suppressants in the market by key players is expected to drive the cough suppressant drugs market growth over the forecast period. For instance, in March 2018, Perrigo Company plc. received the FDA approval for the brand OTC equivalent of Mucinex DM Maximum Strength (Guaifenesin and Dextromethorphan Hydrobromide Extended-release Tablets, 1200 mg/60 mg). Mucinex DM Maximum Strength is indicated to control coughs and to break up mucus, making coughs more productive.

Various key players in the market are conducting research and are evaluating safety and efficacy of various drugs for the treatment of cough. Such initiatives taken by companies is expected to lead to the development of new cough suppressant drugs.

For instance, CSPC ZhongQi Pharmaceutical Technology Co., Ltd. is evaluating the efficacy and safety of benzonatate soft capsules for improving adult cough symptoms, wherein the study is currently (2018) under phase 3 clinical trial.

Moreover, high prevalence of cough is expected to increase the demand for cough suppressant drugs, thereby driving the market growth. For instance, according to the study published by the National Center for Biotechnology Information in 2013, cough is a very common condition and around 12% of the people in Britain experience chronic cough, daily or weekly.

Key features of the study:

  • This report provides in-depth analysis of cough suppressant drugs market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by leading players
  • It profiles leading players in the global cough suppressant drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Perrigo Company plc, Vernalis plc, Tris Pharma Inc., Pfizer Inc., Aytu BioScience, Inc., Acella Pharmaceuticals LLC, Mayne Pharma Inc., Taro Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd, and GlaxoSmithKline plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global cough suppressant drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cough suppressant drugs market
Detailed Segmentation:
  • Global Cough Suppressant Drugs Market, By Disease Type :
  • Dry Cough
  • Wet Cough
  • Global Cough Suppressant Drugs Market, By Drug Type :
  • Dextromethorphan
  • Codeine
  • Noscapine
  • Butamirate
  • Benzonatate
  • Pholcodine
  • Others
  • Global Cough Suppressant Drugs Market, By Age Group:
  • Pediatric
  • Adult
  • Global Cough Suppressant Drugs Market, By Dosage Form:
  • Syrup
  • Tablet
  • Others
  • Global Cough Suppressant Drugs Market, By Distribution Channel:
  • Hospital
  • Retail Pharmacy
  • Online Pharmacy
  • Others
  • Global Cough Suppressant Drugs Market, By Region:
  • North America
  • By Disease Type :
  • Dry Cough
  • Wet Cough
  • By Drug Type:
  • Dextromethorphan
  • Codeine
  • Noscapine
  • Butamirate
  • Benzonatate
  • Pholcodine
  • Others
  • By Product Type
  • Over-the-counter (OTC)
  • Prescription Drug
  • By Age Group
  • Pediatric
  • Adult
  • By Dosage Form
  • Syrup
  • Tablet
  • Others
  • By Distribution Channel
  • Hospital
  • Retail Pharmacy
  • Online Pharmacy
  • Others
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Disease Type :
  • Dry Cough
  • Wet Cough
  • By Drug Type:
  • Dextromethorphan
  • Codeine
  • Noscapine
  • Butamirate
  • Benzonatate
  • Pholcodine
  • Others
  • By Product Type
  • Over-the-counter (OTC)
  • Prescription Drug
  • By Age Group
  • Pediatric
  • Adult
  • By Dosage Form
  • Syrup
  • Tablet
  • Others
  • By Distribution Channel
  • Hospital
  • Retail Pharmacy
  • Online Pharmacy
  • Others
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Disease Type :
  • Dry Cough
  • Wet Cough
  • By Drug Type:
  • Dextromethorphan
  • Codeine
  • Noscapine
  • Butamirate
  • Benzonatate
  • Pholcodine
  • Others
  • By Product Type
  • Over-the-counter (OTC)
  • Prescription Drug
  • By Age Group
  • Pediatric
  • Adult
  • By Dosage Form
  • Syrup
  • Tablet
  • Others
  • By Distribution Channel
  • Hospital
  • Retail Pharmacy
  • Online Pharmacy
  • Others
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Disease Type :
  • Dry Cough
  • Wet Cough
  • By Drug Type:
  • Dextromethorphan
  • Codeine
  • Noscapine
  • Butamirate
  • Benzonatate
  • Pholcodine
  • Others
  • By Product Type
  • Over-the-counter (OTC)
  • Prescription Drug
  • By Age Group
  • Pediatric
  • Adult
  • By Dosage Form
  • Syrup
  • Tablet
  • Others
  • By Distribution Channel
  • Hospital
  • Retail Pharmacy
  • Online Pharmacy
  • Others
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • By Disease Type :
  • Dry Cough
  • Wet Cough
  • By Drug Type:
  • Dextromethorphan
  • Codeine
  • Noscapine
  • Butamirate
  • Benzonatate
  • Pholcodine
  • Others
  • By Product Type
  • Over-the-counter (OTC)
  • Prescription Drug
  • By Age Group
  • Pediatric
  • Adult
  • By Dosage Form
  • Syrup
  • Tablet
  • Others
  • By Distribution Channel
  • Hospital
  • Retail Pharmacy
  • Online Pharmacy
  • Others
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Disease Type :
  • Dry Cough
  • Wet Cough
  • By Drug Type:
  • Dextromethorphan
  • Codeine
  • Noscapine
  • Butamirate
  • Benzonatate
  • Pholcodine
  • Others
  • By Product Type
  • Over-the-counter (OTC)
  • Prescription Drug
  • By Age Group
  • Pediatric
  • Adult
  • By Dosage Form
  • Syrup
  • Tablet
  • Others
  • By Distribution Channel
  • Hospital
  • Retail Pharmacy
  • Online Pharmacy
  • Others
  • By Country:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Perrigo Company plc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Vernalis plc.
  • Tris Pharma Inc.
  • Pfizer Inc.
  • Aytu BioScience, Inc.
  • Acella Pharmaceuticals LLC
  • Mayne Pharma Inc.
  • Taro Pharmaceutical Industries Ltd.
  • Amneal Pharmaceuticals LLC
  • Aurobindo Pharma Ltd.
  • GlaxoSmithKline plc.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Disease Type
Market Snippet, By Drug Type
Market Snippet, By Product Type
Market Snippet, By Age Group
Market Snippet, By Dosage Form
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Novel Product Launch/Approval
Merger-Acquisition Scenario
PEST Analysis
PORTER’s Analysis
Regulatory Scenario
Reimbursement Scenario
Epidemiology
4. Global Cough Suppressant Drugs Market, By Disease Type, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends
Dry Cough
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Wet Cough
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
5. Global Cough Suppressant Drugs Market, By Drug Type, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends
Dextromethorphan
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Codeine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Noscapine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Butamirate
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Benzonatate
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Pholcodine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
6. Global Cough Suppressant Drugs Market, By Product Type, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends
Over-the-counter (OTC)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Prescription Drug
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
7. Global Cough Suppressant Drugs Market, By Age Group, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends
Pediatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Adult
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
8. Global Cough Suppressant Drugs Market, By Distribution Channel, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends
Hospital
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Retail Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Online Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
9. Global Cough Suppressant Drugs Market, By Region, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026
North America
Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Age Group, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
U.S.
Canada
Europe
Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Age Group, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Age Group, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of APAC
Latin America
Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Age Group, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
Central Africa
South Africa
North Africa
Middle East
Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Age Group, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
GCC
Israel
Rest of Middle East
10. Competitive Landscape
Heat Map Analysis
Company Profiles
Perrigo Company plc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Vernalis plc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Tris Pharma Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Aytu BioScience, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Acella Pharmaceuticals LLC
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Mayne Pharma Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Taro Pharmaceutical Industries Ltd
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Amneal Pharmaceuticals LLC
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Aurobindo Pharma Ltd
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline plc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
11. Section
References
Research Methodology
About us and Sales Contact
*Browse 42 market data tables and 40 figures on “Cough Suppressant Drugs Market - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook